Stock Evaluator: Aspire-Lakewood Holdings, Inc. (ASBP)
Aspire-Lakewood Holdings, Inc. ASBP
$9.06
-0.06
-0.66%
September 11, 2026 4:00:00 PM
EST
Volume: 26,785
After Hours: $120.37
0.15
|
0.12%
November 10, 2021 7:59 PM
EST
Volume: 72,713
USD
NASD | DELAYED PRICE
| SECTOR | INDUSTRY |
| Health Care | Pharmaceuticals |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Aspire-Lakewood Holdings, Inc. develops pharmaceutical delivery technology, and designs and manufactures automotive and industrial control systems. The company creates improved formulations of existing pharmaceutical compounds using a nano-technology-based sublingual delivery system designed to enhance medication efficacy and reduce time to therapeutic effect. Its technology enables rapid absorption through under-the-tongue administration, allows medications to bypass hepatic metabolism to improve dose management and bioavailability. The company applies its delivery technology across therapeutic categories including analgesics, pain management and inflammation therapeutics, erectile dysfunction treatments, and traumatic brain injury drugs. Its product offerings include a sublingual aspirin formulation developed using its delivery technology. Its automotive and industrial control system products include mechatronic actuators, human machine interfaces, industrial cables, and cable control systems. Aspire-Lakewood Holdings, Inc. was formerly known as Aspire Biopharma Holdings, Inc. and changed its name to Aspire-Lakewood Holdings, Inc. in September 2026. Aspire-Lakewood Holdings, Inc. was incorporated in 2021 and is based in Estero, Florida.
Financial Summary
| Share Statistics | ASBP | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $12.7 | $609.5 | 7% |
|
| Shares Out (Mil) | 1.0 | 43.4 | 5% |
|
| Institutional Ownership | 20.6% | 83.9% | 10% |
|
| Float (Mil) | 1.1 | 45.7 | 3% |
|
| Beta | 0.11 | 0.73 | 9% |
|
| Avg Daily Volume (000s) | 40 | 309 | 26% |
|
| Price Change (52-week) |
(98.3%) | 64.9% | 2% |
|
| Growth | ASBP | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 6.7% | na |
|
| Net Income (5yr) | na | (1.6%) | na |
|
| EPS (5yr) | na | 15.1% | na |
|
| Dividends (5yr) | na | 0.0% | 0% |
|
| Cash Flow (5yr) | na | (15.0%) | na |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | ASBP | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | na | $317 | na |
|
| Net Income (TTM) (Mil) | ($11) | ($11) | 28% |
|
| EPS (TTM) | ($33.333) | ($0.700) | 2% |
|
| Operating Cash Flow (TTM) (Mil) | ($7) | ($7) | 22% |
|
| Net Cash Flow (TTM) (Mil) | na | $6 | na |
|
| Long-Term Debt (Q1) (Mil) | $0 | $6 | 0% |
|
| Enterprise Value (Q1) (Mil) | ($1) | $525 | 3% |
|
| Valuation | ASBP | Industry Median |
Percentile (All Stocks) |
|
| P/B | 1.00 | 2.61 | 22% |
|
| P/E | na | 17.0 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.0 | na |
|
| Ratios | ASBP | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | (25.0%) | 68.8% | 3% |
|
| Net Margin | na | 0.8% | na |
|
| ROA | (152.1%) | (22.7%) | 3% |
|
| ROE | na | (22.8%) | na |
|
| Liabilities to Assets | 13.2% | 33.1% | 8% |
|
| F-Score | 3 | 3 | 18% |
|
Aspire-Lakewood Holdings, Inc. did not pass any screens on 9/11/2026.
